First Time Loading...
C

Clarus Therapeutics Holdings Inc
NASDAQ:CRXT

Watchlist Manager
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Watchlist
Price: 0.021 USD -19.54% Market Closed
Updated: May 29, 2024

Clarus Therapeutics Holdings Inc
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Clarus Therapeutics Holdings Inc
Short-Term Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Short-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
C
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Short-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Short-Term Debt
$6.3B
CAGR 3-Years
176%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Short-Term Debt
$3.3B
CAGR 3-Years
129%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Short-Term Debt
$7.2B
CAGR 3-Years
120%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Short-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eli Lilly and Co
NYSE:LLY
Short-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Clarus Therapeutics Holdings Inc's Short-Term Debt?
Short-Term Debt
0 USD

Based on the financial report for Dec 31, 2021, Clarus Therapeutics Holdings Inc's Short-Term Debt amounts to 0 USD.